by Vandana Singh | Oct 28, 2026 | General
Geron Corporation (NASDAQ:GERN) shares plunged on Wednesday after the company halted its late-stage cancer program. Independent Panel Recommends Study Discontinuation The hematology biopharmaceutical company decided to discontinue the Phase 3 IMpactMF trial evaluating...
by Vandana Singh | Oct 28, 2026 | General
Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook. Labcorp reported third-quarter adjusted earnings of $4.78, beating the consensus of $4.66. Sales reached $3.81...
by Vandana Singh | Oct 28, 2026 | General
Genmab A/S (NASDAQ:GMAB) stock surged to a 52-week high after the company delivered positive topline findings from its global Phase 3 LiGeR-HN1 clinical trial evaluating petosemtamab, an investigational IgG1-bispecific antibody targeting EGFR and LGR5. Petosemtamab...
by Lekha Gupta | Oct 28, 2026 | General
Old Dominion Freight Line Inc. (NASDAQ:ODFL) stock fell Wednesday despite the trucking company reporting better-than-expected third-quarter 2026 results and issuing a fourth-quarter revenue forecast above Wall Street expectations. The results showed stronger pricing...
by Daragh Thomas | Oct 28, 2026 | General
Steve Eisman accused Anthropic of deliberately omitting third-quarter financial figures from its IPO prospectus, arguing that newer numbers could reveal a sharp slowdown in the artificial intelligence company’s growth. Speaking on Prof G Markets Wednesday, the...
Recent Comments